Each year, we screen over 300 businesses seeking our early stage venture capital. Many have assembled world class teams of scientists or engineers and have proprietary technology that provides competitive advantages in rapidly growing markets. However, they lack the executive leadership required to reach their full potential. Over time, we seek a core group of standby CEOs as potential matches with these opportunities.
Positions are currently available.
We are a diversified early stage investor with a particular focus in biotechnology, medical devices, internet, and information technology. Individuals are screened to establish a pool of qualified candidates. We then attempt to match those individuals with existing portfolio companies or new investment opportunities as they emerge. Candidates that place a greater value on equity participation than current compensation. Consequently the candidate's total compensation is directly related to the success of the company through performance incentives and stock options.